Navigation Links
A rare feat: 2 scientists at Salk score NIH New Innovator Awards
Date:9/13/2012

LA JOLLA, CA--The Salk Institute announced today that researchers Bjrn Lillemeier, and Axel Nimmerjahn, have been named recipients of the prestigious 2012 National Institutes of Health (NIH) Director's New Innovator Award.

The NIH Director's New Innovator Award is a highly selective program with hundreds of researchers from the nation's top scientific institutions competing for the award. Only 51 scientists received the honor this year.

Drs. Lillemeier and Nimmerjahn will each receive $1.5 million over a period of five years. They join a group of young investigators who will receive a portion of approximately $155 million to pursue visionary science that exhibits the potential to transform scientific fields and speed the translation of research into improved health.

"It is extremely rare that a scientist would receive such an honor in his career, and even more exciting that an institute is fortunate enough to have two recipients selected for an NIH Director's New Innovator Award at the same time," said William R. Brody, president, Salk Institute. "We are very proud of Bjrn and Axel and grateful for NIH's support of young researchers who pursue innovative and bold science."

Bjrn Lillemeier is an assistant professor in both the Nomis Foundation Laboratories for Immunobiology and Microbial Pathogenesis and the Waitt Advanced Biophotonics Center. He is also the holder of the Rudolph and Sletten Developmental Chair. The New Innovator award will boost his efforts to understand how cellular communication is controlled in space and time. To this end, he develops unique optical microscopy techniques that visualize the molecular organization of plasma membrane signaling in live cells. A main interest of his laboratory is the processing of signals that cause activation or silencing of T lymphocytes during infections and diseases. His research reveals novel signaling mechanisms that can be utilized to modulate cell functions and target the large number of diseases associated with membrane signaling defects.

Axel Nimmerjahn, an assistant professor in the Waitt Advanced Biophotonics Center and holder of the Richard Allan Barry Developmental Chair, has created and continues to develop novel research tools for dissection of glial cell function in the intact healthy and diseased brain. The New Innovator award will support his research into microglia, the resident immune cells in the brain. Microglia are involved in essentially all brain pathologies and hence better understanding of their signaling mechanisms may lead to new or improved disease prevention and treatment strategies. Nimmerjahn aims to develop novel optical and genetic tools for in vivo dissection of microglia function in superficial and deep regions of the brain. This will provide new fundamental insight into these cell's beneficial and detrimental roles in health and disease.

Established in 2007, The NIH Director's New Innovator Award addresses two important goals: stimulating highly innovative research and supporting promising new investigators. The program supports exceptionally creative new investigators who propose highly innovative projects that have the potential for unusually high impact.


'/>"/>
Contact: Andy Hoang
AHoang@salk.edu
619-861-5811
Salk Institute
Source:Eurekalert  

Related biology news :

1. Stanford scientists develop gene therapy approach to grow blood vessels in ischemic limbs
2. Queens scientists seek vaccine for Pseudomonas infection
3. Scientists produce eye structures from human blood-derived stem cells
4. American Society of Plant Biologists honors early career women scientists
5. Brandeis scientists win prestigious prize for circadian rhythms research
6. Scientists discover new method of proton transfer
7. Salk scientists open new window into how cancers override cellular growth controls
8. WileyChina.com - Now Featuring Bespoke Pages for China’s Life Scientists
9. Scientists win $2 million to study new pathway in development and maintenance of lymphoma
10. UGA scientists reveal genetic mutation depicted in van Goghs sunflower paintings
11. Genetic mutation depicted in van Goghs sunflower paintings revealed by scientists
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A rare feat: 2 scientists at Salk score NIH New Innovator Awards
(Date:4/11/2017)... GARDENS, Fla. , April 11, 2017 /PRNewswire/ ... management and secure authentication solutions, today announced that ... by Intelligence Advanced Research Projects Activity (IARPA) to ... IARPA,s Thor program. "Innovation has been ... and IARPA,s Thor program will allow us to ...
(Date:4/11/2017)... , April 11, 2017 NXT-ID, Inc. ... technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate governance ... Gino ... we look forward to their guidance and benefiting from their ...
(Date:4/5/2017)... -- Today HYPR Corp. , leading innovator in ... the HYPR platform is officially FIDO® Certified . ... that empowers biometric authentication across Fortune 500 enterprises and ... 15 million users across the financial services industry, however ... suites and physical access represent a growing portion of ...
Breaking Biology News(10 mins):
(Date:4/27/2017)... ... April 27, 2017 , ... During the ... review how testing for 1,25-Dihydroxyvitamin D can enhance clinical practice. Participants will learn ... 1,25 dihydroxyvitamin D. , Dr. Gregory Plotnikoff, senior consultant with Minnesota Personalized Medicine, ...
(Date:4/27/2017)... , April 27, 2017  Pendant Biosciences, Inc. ... innovative surface modification and drug delivery technologies, today announced ... Innovation, JLABS @ Toronto . ... Officer of Pendant Biosciences, noted, "We are excited to ... community, and are honored to be the ...
(Date:4/26/2017)... ... April 25, 2017 , ... LABS, Inc. (LABS) announced in December ... its extensive test menu: Nucleic Acid Testing (NAT) for ZIKV; and Enzyme Immunoassays (EIAs) ... to offer NAT screening for blood donors under an Investigational New Drug (IND) study ...
(Date:4/25/2017)... ... April 25, 2017 , ... As part of the Stago EdVantage Virtual ... testing for DIC in order to illuminate this clinical problem for people unfamiliar with ... patients resulting in a high degree of morbidity and mortality. DIC is a confusing ...
Breaking Biology Technology: